Feder M K, Gilbert F
J Natl Cancer Inst. 1983 Jun;70(6):1051-6.
Tumor samples, obtained from a single patient at two points in his illness, have enabled us to study clonal evolution in a neuroblastoma. Cells from the primary tumor demonstrated considerable heterogeneity in terms of chromosome number; cells from 4 subsequent metastases were all nearly diploid; and cells from a tumor produced in a mouse by the injection of cells from the primary tumor were hypotriploid in modal number. All of the tumor samples contained the same marker chromosome rearrangements, indicating their origin from a common precursor. Each of the cell lines analyzed (including those from the patient's metastases, those from the tumor in a mouse, and those from the primary tumor after 11 months in continuous culture) also contained different and distinguishing chromosome abnormalities. The differences in karyotype among these tumor samples and cell lines presumably reflect the different selection pressures at work in each instance.
从一名患者病程中的两个时间点获取的肿瘤样本,使我们能够研究神经母细胞瘤的克隆进化。原发肿瘤的细胞在染色体数目方面表现出相当大的异质性;来自随后4个转移灶的细胞几乎都是二倍体;通过注射原发肿瘤细胞在小鼠体内产生的肿瘤细胞,其众数染色体数目为亚三倍体。所有肿瘤样本都含有相同的标记染色体重排,表明它们起源于一个共同的前体。分析的每个细胞系(包括来自患者转移灶的细胞系、来自小鼠体内肿瘤的细胞系以及连续培养11个月后的原发肿瘤细胞系)也都含有不同且独特的染色体异常。这些肿瘤样本和细胞系之间核型的差异大概反映了每个实例中起作用的不同选择压力。